The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells

The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells

Hong-qing Zhou,1,* Ming-sheng Liu,1,* Ti-bin Deng,1 Ping-bo Xie,1 Wei Wang,1 Tao Shao,1 Yao Wu,1 Peng Zhang2 1Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing City 655000, Yunnan Province, People’s Republic of China; 2Department of Urology, State Key...

Full description

Bibliographic Details
Main Authors: Zhou HQ, Liu MS, Deng TB, Xie PB, Wang W, Shao T, Wu Y, Zhang P
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:OncoTargets and Therapy
Subjects:
Bladder cancer
Radiofrequency ablation
SB431542
Epithelial-mesenchymal transition
Online Access:https://www.dovepress.com/the-tgf-betasmad-pathway-inhibitor-sb431542-enhances-the-antitumor-eff-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-tgf-betasmad-pathway-inhibitor-sb431542-enhances-the-antitumor-eff-peer-reviewed-article-OTT

Similar Items